Institute of Laboratory Medicine, Kepler Universitätsklinikum, Krankenhausstrasse 9, 4021, Linz, Austria.
Institute of Laboratory Medicine, Medical University Graz, Auenbruggerplatz 2, 8036, Graz, Austria.
Appl Microbiol Biotechnol. 2017 Oct;101(19):7259-7269. doi: 10.1007/s00253-017-8436-9. Epub 2017 Aug 19.
The widespread use of molecular PCR-based assays in analytical and clinical laboratories brings about the need for test-specific, stable, and reliable external controls (EC) as well as standards and internal amplification controls (IC), in order to arrive at consistent test results. In addition, there is also a growing need to produce and provide stable, well-characterized molecular controls for quality assurance programs. In this study, we describe a novel approach to generate armored double-stranded DNA controls, which are encapsulated in baculovirus (BV) particles of the species Autographa californica multiple nucleopolyhedrovirus. We used the well-known BacPAK™ Baculovirus Expression System (Takara-Clontech), removed the polyhedrin promoter used for protein expression, and generated recombinant BV-armored DNAs. The obtained BV-armored DNAs were readily extracted by standard clinical DNA extraction methods, showed favorable linearity and performance in our clinical PCR assays, were resistant to DNase I digestion, and exhibited marked stability in human plasma and serum. BV-armored DNA ought to be used as ECs, quantification standards, and ICs in molecular assays, with the latter application allowing for the entire monitoring of clinical molecular assays for sample adequacy. BV-armored DNA may also be used to produce double-stranded DNA reference materials for, e.g., quality assurance programs. The ease to produce BV-armored DNA should make this approach feasible for a broad spectrum of molecular applications. Finally, as BV-armored DNAs are non-infectious to mammals, they may be even more conveniently shipped than clinical specimen.
分子聚合酶链反应(PCR)检测在分析和临床实验室中的广泛应用,需要特定于检测的、稳定且可靠的外部对照(EC)以及标准和内部扩增对照(IC),以便获得一致的检测结果。此外,还需要生产和提供稳定、特征明确的分子对照品,以用于质量保证计划。在本研究中,我们描述了一种生成装甲双链 DNA 对照品的新方法,这些对照品被包被在杆状病毒(BV)颗粒中,病毒株为 Autographa californica 多角体病毒。我们使用了众所周知的 BacPAK™杆状病毒表达系统(Takara-Clontech),去除了用于蛋白表达的多角体蛋白启动子,并生成了重组 BV 装甲 DNA。获得的 BV 装甲 DNA 可通过标准临床 DNA 提取方法轻松提取,在我们的临床 PCR 检测中表现出良好的线性和性能,对 DNA 酶 I 消化具有抗性,并在人血浆和血清中表现出明显的稳定性。BV 装甲 DNA 可作为 EC、定量标准和 IC 用于分子检测,后者的应用可实现对临床分子检测样本充足性的全面监测。BV 装甲 DNA 也可用于生产双链 DNA 参考物质,例如用于质量保证计划。生产 BV 装甲 DNA 的简便性,应使该方法适用于广泛的分子应用。最后,由于 BV 装甲 DNA 对哺乳动物没有感染性,因此与临床标本相比,它们可能更便于运输。